These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24362548)

  • 61. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetic alterations underlying autoimmune diseases.
    Aslani S; Mahmoudi M; Karami J; Jamshidi AR; Malekshahi Z; Nicknam MH
    Autoimmunity; 2016; 49(2):69-83. PubMed ID: 26761426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
    Ramakrishnan S; Pili R
    Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Approaches to target the genome and its epigenome in cancer.
    Chapman-Rothe N; Brown R
    Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epigenetic alteration and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Front Genet; 2013 Dec; 4():258. PubMed ID: 24348513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epigenetics changes associated to environmental triggers in autoimmunity.
    Cañas CA; Cañas F; Bonilla-Abadía F; Ospina FE; Tobón GJ
    Autoimmunity; 2016; 49(1):1-11. PubMed ID: 26369426
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The roles of microRNAs in epigenetic regulation.
    Yao Q; Chen Y; Zhou X
    Curr Opin Chem Biol; 2019 Aug; 51():11-17. PubMed ID: 30825741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chromatin, cancer and drug therapies.
    Cortez CC; Jones PA
    Mutat Res; 2008 Dec; 647(1-2):44-51. PubMed ID: 18691602
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
    Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Crosstalk between miRNAs and DNA Methylation in Cancer.
    Saviana M; Le P; Micalo L; Del Valle-Morales D; Romano G; Acunzo M; Li H; Nana-Sinkam P
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
    Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
    Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
    Schnekenburger M; Florean C; Dicato M; Diederich M
    Curr Top Med Chem; 2016; 16(7):745-76. PubMed ID: 26303418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epigenetics of CD4+ T cells in autoimmune diseases.
    Wang Z; Chang C; Lu Q
    Curr Opin Rheumatol; 2017 Jul; 29(4):361-368. PubMed ID: 28362657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical advances in targeting epigenetics for cancer therapy.
    Feng S; De Carvalho DD
    FEBS J; 2022 Mar; 289(5):1214-1239. PubMed ID: 33545740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Histone modifications as a platform for cancer therapy.
    Espino PS; Drobic B; Dunn KL; Davie JR
    J Cell Biochem; 2005 Apr; 94(6):1088-102. PubMed ID: 15723344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicroRNA epigenetic signatures in human disease.
    Piletič K; Kunej T
    Arch Toxicol; 2016 Oct; 90(10):2405-19. PubMed ID: 27557899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.